Amlodipine and Lisinopril Combination Therapy for Hypertension
Yes, amlodipine and lisinopril can and should be used together for hypertension management—this combination is explicitly recommended by ACC/AHA guidelines as a rational, complementary pairing that produces additive blood pressure lowering effects. 1, 2
Guideline-Based Rationale for Combination
The 2017 ACC/AHA guidelines specifically endorse combining ACE inhibitors (like lisinopril) with calcium channel blockers (like amlodipine) because they have complementary mechanisms of action. 1 Thiazide diuretics may stimulate the renin-angiotensin-aldosterone system, and adding an ACE inhibitor blocks this compensatory response, resulting in additive BP lowering. 1 The same principle applies when combining CCBs with ACE inhibitors—each targets different pathways controlling blood pressure. 2
Both amlodipine and lisinopril are designated as first-line agents for hypertension treatment. 1, 3, 4 The European Society of Hypertension/ESC guidelines list calcium antagonist plus ACE inhibitor as one of the preferred combinations in the general hypertensive population. 2
When to Use Combination Therapy
Initiate combination therapy with two first-line agents when:
- Stage 2 hypertension is present (BP ≥140/90 mmHg or more than 20/10 mmHg above target) 1
- Initial BP is grade 2 or 3 (≥160/100 mmHg) 2
- Total cardiovascular risk is high or very high 2
Start with monotherapy when:
- Stage 1 hypertension (130-139/80-89 mmHg) with low to moderate cardiovascular risk 1, 2
- Then add the second agent if target BP <130/80 mmHg is not achieved 1
Clinical Evidence of Efficacy
Research demonstrates that the amlodipine-lisinopril combination produces significantly greater BP reduction than either agent alone. 5 In a randomized crossover study, the combination of just 2.5 mg amlodipine with 5 mg lisinopril produced more significant BP lowering in a higher percentage of patients than individual low doses. 5
A 12-week trial showed that low-dose combined treatment with amlodipine and lisinopril achieved target BP in more patients and produced greater systolic and diastolic BP reductions than monotherapy with either drug alone. 6 Both drugs together were well-tolerated and efficacious in patients with stage 2 hypertension, with response rates approaching 100%. 7
Special Population Considerations
For Black patients: This combination is particularly appropriate because ACE inhibitors like lisinopril are less effective as monotherapy in Black patients compared to CCBs or thiazides. 1, 4 However, the combination of ACE inhibitor with CCB produces similar BP lowering in Black patients as in other racial groups. 2 The ALLHAT trial showed that in Black patients, ACE inhibitors were notably less effective than CCBs in preventing heart failure and stroke. 1
For patients with diabetes: Both agents are appropriate, though specific comorbidities (like diabetic nephropathy) may favor ACE inhibitors. 1
For patients with heart failure: Amlodipine can be used as a step 3 agent in heart failure patients with persistent hypertension despite treatment with ACE inhibitors, beta-blockers, and mineralocorticoid receptor antagonists. 8
Practical Implementation
Dosing strategy:
- Start with amlodipine 2.5-5 mg plus lisinopril 5-10 mg once daily 5, 6
- Titrate upward if needed: amlodipine up to 10 mg, lisinopril up to 40 mg 3, 4
- Fixed-dose combination tablets are available and can improve compliance 2
Monitoring requirements:
- Check basic metabolic panel for renal function and potassium, especially with lisinopril 4
- Monitor for ACE inhibitor-related cough (occurs in some patients) 2
- Watch for angioedema risk, particularly in Black patients and Asian Americans 2
- Assess BP response within 1-2 weeks 9
When Combination Fails
If BP remains uncontrolled on amlodipine plus lisinopril, add a thiazide diuretic rather than a beta-blocker. 10 A randomized crossover study demonstrated that in patients not adequately controlled on amlodipine 5 mg and lisinopril 10 mg daily, adding bendroflumethiazide 5 mg caused a significantly greater fall in BP compared to adding atenolol 100 mg. 10
Critical Contraindications
Never combine lisinopril with:
High-quality RCT data demonstrate that simultaneous administration of RAS blockers increases cardiovascular and renal risk. 1
Mechanism and Pharmacology
Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to vasodilation and decreased sodium retention. 4 Amlodipine blocks calcium channels in vascular smooth muscle, causing direct vasodilation. 3 These complementary mechanisms explain the additive effect when combined. 1, 2
The combination addresses multiple pathways: lisinopril suppresses the renin-angiotensin-aldosterone system while amlodipine provides direct vasodilation independent of this system. 4 This is particularly valuable since many patients require more than one drug to achieve BP goals. 3
Cost-Effectiveness
Low-dose combined treatment with lisinopril and amlodipine is more cost-efficient than higher-dose monotherapy with either agent. 6 Additionally, lisinopril may correct some CNS side effects associated with amlodipine monotherapy. 6